Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions Our population-based quasi-experimental retrospective ...
SAN DIEGO--(BUSINESS WIRE)--Inocras, an industry leader in whole genome sequencing and bioinformatics, released a new study highlighting the clinical validation of its CancerVision Target-Enhanced ...
Hosted on MSN
Genomic testing aids precision therapy and tissue of origin identification for cancers whose primary site is unknown
A new study highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and identify the tissue of origin for cancers whose primary site is unknown, ...
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical ...
STAMFORD, Conn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced new data to be presented ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Qiagen N.V. is placed seventh among them. Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback